Dr Toll’s presentation will focus on the rise of e-cigarettes as the dominant form of tobacco use in the United States (US) and the need for the development of treatments focusing on e-cigarette reduction and cessation. The supremacy of e-cigarette use by US youths will be briefly discussed, along with data showing that the majority… Read more »
Archives: Seminars
PM Chair -Welcome & Introductions
Industry, enforcement and criminality
In this presentation, Kate Pike from Trading Standards will discuss how criminals have entered the UK vaping space and the size and scale of the challenge they present. These criminal groups are solely motivated by making as much money as possible from this commodity. They have no concern for public health, safety, compliance, the environment,… Read more »
The Tobacco and Vapes Bill: Current status and progress update on behalf of the DHSC
The Tobacco and Vapes Bill was introduced in the House of Commons on 5 November 2024 and is currently progressing through the House of Lords. The Bill fulfils the Government’s manifesto commitment to ensure that the next generation will never legally be sold tobacco products and that vapes will be banned from being branded and… Read more »
PANEL: Discussion and Open floor Q&A
The UK and NZ approach has been controversial. Is there an alternative model that has worked better? What would the role of tobacco control be in a post-smoking era? How will we know when — or if — we get things right— what are the measures of success?
CLOSING KEYNOTE: Priorities & purpose: the role of public health in reducing the harms from smoking
In this session, Martin will reflect on his 20 years in tobacco control and the 20 preceding years in HIV prevention, drawing lessons for the current challenges in nicotine policy. He will explore the importance of fully utilising the evidence, maintaining public trust, and promoting public health with clear-sighted prioritisation. Martin will talk about his… Read more »
Lessons from New Zealand
Aotearoa New Zealand was one of the first countries to run clinical trials of e-cigarettes, evaluate relative risk, and endorse their use to stop smoking. An early commitment to objective, evidence-based approaches made New Zealand an early adopter of vaping for harm reduction. Easy access, low prices and support from the government for stopping smoking saw… Read more »
Global regulatory developments & forecasting the novel nicotine sector
Building on insights from the COP and recent European regulatory proposals, Tim Phillips from ECigIntelligence will analyse the changing nicotine product landscape, global regulations, and the rise in enforcement worldwide. Tim will highlight where product development is occurring and consider what this could mean for the adoption of new nicotine products over the next decade.
The changing face of nicotine use: generational shifts, older adults, and implications for policy
Nicotine use in England is evolving rapidly. Among younger adults, daily cigarette smoking has fallen sharply, with vaping now more common than smoking. In contrast, older adults continue to follow more traditional smoking patterns and are more uncertain about the relative harms of e-cigarettes – despite evidence that these products work just as well for… Read more »
Fighting for science: the importance of incorporating evidence on pouches and e-cigarettes into policy
The evidence is clear that switching from smoking to vaping reduces health risks and can save lives. Though more preliminary, evidence on oral nicotine pouches suggests the same. But as evidence grows in this space, public opinion continues to move in the opposite direction, with valuable opportunities to reduce the burden of tobacco use missed… Read more »




Recent Comments